By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ProStrakan Group 

Galashiels      Scotland
Phone: n/a Fax:



Company News
ProStrakan Group Rebrands As Kyowa Kirin 4/18/2016 12:58:05 PM
ProStrakan Group Launching SANCUSO (Granisetron Transdermal System) in European Union With 3M Drug Delivery Systems as Manufacturer 9/30/2013 10:54:01 AM
ProStrakan Group Acquires Breast Cancer Product for $21.7 Million 10/1/2012 7:14:44 AM
Orexo AB Acquires All US Rights for ProStrakan Group's Abstral and Receives a Net Cash Consideration of £55 Million 6/4/2012 7:52:09 AM
FDA Approves ProStrakan Group's Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 1/3/2012 7:07:08 AM
ProStrakan Group Receives FDA Approval for Rectiv(TM) for the Treatment of Moderate to Severe Pain Associated With Chronic Anal Fissures 6/22/2011 7:43:13 AM
ProStrakan Group's ABSTRAL(R) (fentanyl) Sublingual Tablets CII, First-in-class, Sublingual, Immediate Release Opioid for Managing Breakthrough Cancer Pain, Now Available in the U.S. 4/4/2011 7:05:34 AM
Testosterone Gel from ProStrakan Group Shows Effects on Diabetes 3/25/2011 7:29:48 AM
Japanese Company Kyowa Hakko Kirin to Buy ProStrakan Group for £292 Million 2/22/2011 8:14:12 AM
ProStrakan Group Chooses RelayHealth for Approved Abstral REMS Program 1/20/2011 8:12:30 AM